| 000 | 01567cam a2200373 i 4500 | ||
|---|---|---|---|
| 005 | 20250918235656.0 | ||
| 008 | 140716s2013 ne af b 001 0 eng | ||
| 020 |
_a9780123948106 _cRM570.86 |
||
| 020 | _a012394810X | ||
| 039 | 9 |
_a201509141152 _bruzini _c201504281208 _dzainol _y07-16-2014 _zfida |
|
| 040 |
_aNLM _beng _erda _cNLM _dUKMGB _dOCLCO _dIXA _dDLC _dOCLCO _dYDXCP _dUKM _erda |
||
| 090 | _aQV35.N812 2013 9 | ||
| 090 |
_aQV35 _b.N812 2013 9 |
||
| 245 | 0 | 0 |
_aNonclinical development of novel biologics, biosimilars, vaccines, and specialty biologics / _cedited by Lisa M. Plitnick, MS, PhD and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA. |
| 264 | 1 |
_aAmsterdam : _bElsevier, AP, Academic Press is an imprint of Elsevier, _c2013. |
|
| 300 |
_axv, 416 pages, 8 unnumbered pages of plates : _billustrations (some color) ; _c25 cm |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 | _aBiopharmaceutics. | |
| 650 | 2 | _aBiological products. | |
| 650 | 2 | _aBiologicals. | |
| 700 | 1 |
_aPlitnick, Lisa M., _eeditor. |
|
| 700 | 1 |
_aHerzyk, Danuta J., _eeditor. |
|
| 907 |
_a.b15952587 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV35.N812 2013 9 |
||
| 914 | _avtls003565157 | ||
| 990 | _azr | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2014-03-07 _cm _da _feng _gne _y0 _z.b15952587 |
||
| 999 |
_c574637 _d574637 |
||